Rokos Capital Management »

Intellia Therapeutics shares owned by Rokos Capital Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Rokos Capital Management from 13F filings

Historical chart of Rokos Capital Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Rokos Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Rokos Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $45M 1.5M 30.48
2023-09-30 $44M 1.4M 31.90
2023-06-30 $57M 1.4M 40.65
2023-03-31 $52M 1.4M 37.15
2022-12-31 $28M 826k 34.37
2022-09-30 $17M 291k 57.56
2022-06-30 $17M 332k 50.66
2022-03-31 $8.1M 112k 72.49